Price To Earnings Ratio 34.98 | Sector PE 69.55 |
PB Ratio 4.42 | Sector PB 8.96 |
EPS 16.72 | Dividend Yield 0.35 |
Today's Volume 4.792 M | 5 Day Avg. Volume 2.342 M |
PEG Ratio -1.62 | Market Cap. ₹ 14,180.00 Cr. |
Granules India Limited is an Indian pharmaceutical manufacturer. The company operates through the pharmaceutical segment. Its geographical segments include India and non-India. The company is present in the entire value chain of pharmaceutical manufacturing, including active ingredients (API), pharmaceutical formulation intermediates (PFI) and finished dosage forms (FD). It has more than eight manufacturing units, of which about seven are located in India and one in the United States. The company sells its products in global markets, including the United States, Canada, Latin America, Europe, Asia and India. The Company's wholly owned subsidiaries are Granules USA Inc, Granules Pharmaceuticals Inc, Granules Europe Limited and Granules Lifesciences Private Limited.